Keyphrases
Standard of Care
100%
Recurrent Prostate Cancer
100%
Biochemical Recurrence
100%
Local Therapy
100%
Androgen Deprivation Therapy
50%
Prostate-specific Antigen Level
50%
Clinical Trials
25%
Metabolic Syndrome
25%
Natural History
25%
Patient Demographics
25%
Natural Products
25%
Treatment Options
25%
Radiation Therapy
25%
Prostatectomy
25%
Sarcopenia
25%
Vascular Disease
25%
Bone Loss
25%
U.S. Food
25%
Rising Prostate-specific Antigen
25%
Targeted Agents
25%
Localized Prostate Cancer
25%
Early Change
25%
Prostate-specific Antigen
25%
Disease States
25%
Misinterpretation
25%
Impotence
25%
Patient Anxiety
25%
Distant Metastasis
25%
Hot Flashes
25%
Biochemical Progression
25%
Clinical Progression
25%
Hormonal Therapy
25%
Imminent Death
25%
Non-hormonal Treatment
25%
Medicine and Dentistry
Prostate Cancer
100%
Biochemical Recurrence
100%
Local Therapy
100%
Disease
75%
Prostate Specific Antigen
75%
Androgen Deprivation Therapy
50%
Clinical Trial
25%
Sarcopenia
25%
Prostatectomy
25%
Metabolic Syndrome
25%
Patient Population
25%
Hot Flush
25%
Radiation Therapy
25%
Natural Product
25%
Hormone Therapy
25%
Distant Metastasis
25%
Vascular Disease
25%
Drug
25%
Immunotherapy
25%
Osteolysis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Biochemical Recurrence
100%
Prostate Specific Antigen
75%
Disease
75%
Androgen
50%
Clinical Trial
25%
Drug
25%
Hormone Cancer Therapy
25%
Metabolic Syndrome X
25%
Natural Product
25%
Distant Metastasis
25%
Sarcopenia
25%
Hot Flush
25%
Immunotherapy
25%
Vascular Disease
25%